Proxygen and Merck collaborates to develop molecular glue degraders

The companies will jointly identify and develop molecular glue degraders up to a clinical candidate stage.

C2i Genomics and Karkinos Healthcare partner to bring AI-powered cancer detection and monitoring to India

C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India

Phygital model of med-tech seems to be quite Promising: opines Expert

To address the preventive & primary healthcare delivery gaps in India

Fortis Healthcare opens Healthcare Information Centre at Tirupati

The information center has been established with the aim of providing Fortis Healthcare’s world-class healthcare services accessible to the people of Tirupati.

David Kendall named Zealand Pharma CMO

Follows Zealand Pharma’s appointment of Adam Steensberg as CEO and decision to refocus strategy

Mitsubishi Tanabe Pharma America presents 48-week results from phase 3 safety clinical study of Radicava ORS

Radicava ORS was approved by the U.S. Food and Drug Administration (FDA) on May 12, 2022

GSK to acquire clinical-stage biopharmaceutical company Affinivax for US$ 3.3 billion

GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones

Evonik to build new lipid production facility for mRNA-based therapies in U.S.

Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025

Ovensa and Celanese to collaborate to advance precision drug delivery

USFDA accepts dupilumab for priority review in adults with prurigo nodularis

Dupixent would be the first and only medicine specifically indicated to treat prurigo nodularis in the U.S., if approved